Form 4 for EVMN Evommune, Inc.
Accepted 2025-11-12 00:00:00 ET · period of report 2025-11-07 · accession 0002094941-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2025-11-12 | 2025-11-07 | EVMN | Verduyn-van Weegen Felice Isabel | Dir, 10% | C - Cnv Deriv | — | +3.37M | 3.37M | New | — |
| DI | 2025-11-12 | 2025-11-07 | EVMN | Verduyn-van Weegen Felice Isabel | Dir, 10% | P - Purchase | $16.00 | +1.56M | 4.93M | +46% | +$25.00M |
| DMI | 2025-11-12 | 2025-11-07 | EVMN | Verduyn-van Weegen Felice Isabel | Dir, 10% | C - Cnv Deriv | — | -27.17M | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-07 | C | A | 3,367,133 | — | 3,367,133 | I By LSP 7 Cooperatief U.A. | — | — | (F1) Each share of Series A Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration on a 1-for-7.9557 basis and had no expiration date. (F2) Each share of Series B Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's IPO for no additional consideration on a 1-for-7.8721 basis and had no expiration date. (F3) Each share of Series C Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's IPO for no additional consideration on a 1-for-8.518 basis and had no expiration date. (F4) These securities are held by LSP 7 Cooperatief U.A. ("LSP 7"). LSP 7 Management BV ("LSP 7 Management") may be deemed to beneficially own these securities. As managing directors of LSP 7 Management, each of Martijn Kleijwegt, Rene Kuijten and Joachim Rothe may also be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest, if any, therein. |
| 2 | Common | Common Stock | 2025-11-07 | P | A | 1,562,500 | $16.00 | 4,929,633 | I By LSP 7 Cooperatief U.A. | — | — | (F4) These securities are held by LSP 7 Cooperatief U.A. ("LSP 7"). LSP 7 Management BV ("LSP 7 Management") may be deemed to beneficially own these securities. As managing directors of LSP 7 Management, each of Martijn Kleijwegt, Rene Kuijten and Joachim Rothe may also be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest, if any, therein. |
| 3 | Derivative | Series B Preferred Stock | 2025-11-07 | C | D | 5,090,000 | — | 0 | I By LSP 7 Cooperatief U.A. | — · — to — | 646,587 Common Stock | (F2) Each share of Series B Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's IPO for no additional consideration on a 1-for-7.8721 basis and had no expiration date. (F4) These securities are held by LSP 7 Cooperatief U.A. ("LSP 7"). LSP 7 Management BV ("LSP 7 Management") may be deemed to beneficially own these securities. As managing directors of LSP 7 Management, each of Martijn Kleijwegt, Rene Kuijten and Joachim Rothe may also be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest, if any, therein. |
| 4 | Derivative | Series C Preferred Stock | 2025-11-07 | C | D | 6,585,011 | — | 0 | I By LSP 7 Cooperatief U.A. | — · — to — | 773,069 Common Stock | (F3) Each share of Series C Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's IPO for no additional consideration on a 1-for-8.518 basis and had no expiration date. (F4) These securities are held by LSP 7 Cooperatief U.A. ("LSP 7"). LSP 7 Management BV ("LSP 7 Management") may be deemed to beneficially own these securities. As managing directors of LSP 7 Management, each of Martijn Kleijwegt, Rene Kuijten and Joachim Rothe may also be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest, if any, therein. |
| 5 | Derivative | Series A Preferred Stock | 2025-11-07 | C | D | 15,493,466 | — | 0 | I By LSP 7 Cooperatief U.A. | — · — to — | 1,947,477 Common Stock | (F1) Each share of Series A Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration on a 1-for-7.9557 basis and had no expiration date. (F4) These securities are held by LSP 7 Cooperatief U.A. ("LSP 7"). LSP 7 Management BV ("LSP 7 Management") may be deemed to beneficially own these securities. As managing directors of LSP 7 Management, each of Martijn Kleijwegt, Rene Kuijten and Joachim Rothe may also be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest, if any, therein. |